Compound or Trial
|
Status
|
Company or Center
|
Tamoxifen
|
Enrollment Closed |
The University of Wisconsin-Madison
|
Thalidomide
|
Enrollment Closed |
Dartmouth-Hitchcock Medical Center
|
| Diaphragm Training |
Enrollment Closed |
Beth Israel Deaconess Medical Center |
| National Registry of Veterans with ALS |
Enrollment Closed |
Durham, North Carolina VAMC |
Combination Therapy
Selection Trial in ALS
|
Enrollment Closed |
Multicenter |
Sodium Phenylbutyrate
|
Enrollment Closed |
Multicenter |
| The Vest |
Enrollment Closed |
Hill-Rom
|
| Creatine |
Enrollment Closed |
The Carolinas Neuromuscular/ALS Center |
| Myotrophin® |
Enrollment Closed |
Cephalon |
| Celebrex |
Study Closed |
Northeast ALS Consortium |
| NEOTROFINTM |
Study Closed |
NeoTherapeutics, Inc. |
| NAALADase |
Study Closed |
Guilford Pharmaceuticals Inc. |
| Neurodex |
Study Complete |
Avanir Pharmaceuticals |
| Rilutek® |
FDA approved drug currently available |
Aventis S.A. |
| Oxandrolone |
Study Completed |
The Carolinas Neuromuscular/ALS MDA Center |
| Pilot CoQ10 |
Enrollment Closed |
Eleanor and Lou Gehrig ALS Center at Columbia University |
| High Dose Coenzyme Q10 |
Enrollment Closed |
The Eleanor and Lou Gehrig MDA/ALS Research Center |
| Pilot CoQ10 with imaging |
Enrollment Closed |
Eleanor and Lou Gehrig ALS Center at Columbia University |
| Topiramate (Topamax) |
Study Completed |
North Eastern ALS Consortium |
| Xaliproden |
Preliminary analysis released 9/5/00 |
Sanofi-Synthelabo Inc. |
| Indinavir |
Study Completed |
Beth Israel Medical Center |
| Creatine |
Study Completed |
North Eastern ALS Consortium |
| Creatine |
Study Completed |
The West Virginia University School of Medicine |
| Minocycline Investigation |
Enrollment Closed |
Eleanor and Lou Gehrig ALS Center at Columbia University |
| Buspirone Investigation |
Study Completed |
Multicenter ALS |
